4//SEC Filing
FEINBERG LARRY N 4
Accession 0001104659-20-072060
CIK 0000926617other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:03 PM ET
Size
12.7 KB
Accession
0001104659-20-072060
Insider Transaction Report
Form 4
FEINBERG LARRY N
10% Owner
Transactions
- Exercise of In-Money
Warrants to acquire Common Stock
2020-06-08−463,298→ 0 total(indirect: See footnote)Exercise: $1.80From: 2017-08-17Exp: 2020-06-08→ Common Stock (463,298 underlying) - Exercise of In-Money
Common Stock
2020-06-08$1.80/sh+463,298$833,936→ 6,137,052 total(indirect: See footnote)
Holdings
- 1,555,555(indirect: See footnote)
Common Stock
- 2,595,980(indirect: See footnote)
Common Stock
ORACLE PARTNERS LP
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2020-06-08$1.80/sh+463,298$833,936→ 6,137,052 total(indirect: See footnote) - Exercise of In-Money
Warrants to acquire Common Stock
2020-06-08−463,298→ 0 total(indirect: See footnote)Exercise: $1.80From: 2017-08-17Exp: 2020-06-08→ Common Stock (463,298 underlying)
Holdings
- 2,595,980(indirect: See footnote)
Common Stock
- 1,555,555(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]These securities are owned by Oracle Partners, LP. ("Partners").
- [F2]These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners").
- [F3]These securities are owned by Oracle Ten Fund, L.P. ("Ten Fund").
- [F4]Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund.
- [F5]Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them.
- [F6]The original Warrant expiration date was 2/17/2022, which date was accelerated by the Issuer to 6/8/2020 upon notice to the Reporting Persons.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0000926475
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:03 PM ET
- Size
- 12.7 KB